Linked Data API

Show Search Form

Search Results

1000273
registered interest false more like this
date less than 2018-11-02more like thismore than 2018-11-02
answering body
Foreign and Commonwealth Office more like this
answering dept id 16 more like this
answering dept short name Foreign and Commonwealth Office more like this
answering dept sort name Foreign and Commonwealth Office more like this
hansard heading Wildlife: Smuggling more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Foreign and Commonwealth Affairs, how many nations have now signed up to the London Declaration from the International Wildlife Trade Conference 2018; and what assessment he has made of the implications of that number for the endangered species trade. more like this
tabling member constituency Hendon more like this
tabling member printed
Dr Matthew Offord more like this
uin 187342 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2018-11-12more like thismore than 2018-11-12
answer text <p>57 countries have adopted the London 2018 Declaration committing to action to protect endangered species around the globe, with more expected to sign. This important pledge of international action reflects the success of the Illegal Wildlife Trade Conference in London in October, which was attended by more than 70 countries and more than 400 organisations. The conference focused the minds of international governments on the issue and energized global cooperation to fight the illegal wildlife trade. We will continue to work with our international partners to make progress on commitments pledged at the event.</p><p>We do not have direct information on the likely impact that action by the 57 countries who adopted the London <ins class="ministerial">2018 </ins>Declaration will have on endangered species, but the growing number of signatories <ins class="ministerial">signifies </ins>growing global ambition to <del class="ministerial">funding</del> <ins class="ministerial">tackling </ins>the illegal wildlife trade, which will increase the protection for <del class="ministerial">endagered</del> <ins class="ministerial">endangered </ins>species.</p>
answering member constituency Cities of London and Westminster more like this
answering member printed Mark Field more like this
question first answered
less than 2018-11-12T16:27:27.317Zmore like thismore than 2018-11-12T16:27:27.317Z
question first ministerially corrected
less than 2018-11-23T15:08:04.16Zmore like thismore than 2018-11-23T15:08:04.16Z
answering member
1405
label Biography information for Mark Field more like this
previous answer version
84424
answering member constituency Cities of London and Westminster more like this
answering member printed Mark Field more like this
answering member
1405
label Biography information for Mark Field more like this
tabling member
4006
label Biography information for Dr Matthew Offord more like this
100049
registered interest false more like this
date less than 2014-10-21more like thismore than 2014-10-21
answering body
Department for Transport more like this
answering dept id 27 more like this
answering dept short name Transport more like this
answering dept sort name Transport more like this
hansard heading East Coast Main Line more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government whether the long-term access rights for Grand Central on the East Coast Main Line require them to pay the same access charge as Intercity East Coast; and, if not, why not. more like this
tabling member printed
Lord Bradshaw more like this
uin HL2255 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-28more like thismore than 2014-10-28
answer text <p>Grand Central will not pay the same access charges as Intercity East Coast as Open Access Operators do not pay Fixed Track Access Charges (FTAC). However, both Franchised and Open Access Operators pay Variable Track Access Charges (VTAC) since these are set to reflect the direct ‘wear and tear’ costs that train services impose on the network when they are run.</p><p> </p><p>For Control Period 5 (CP5) the Office of Rail Regulation (ORR) has held <ins class="ministerial">the Capacity Charge element of VTAC at CP4 levels for services currently run by existing passenger Open Access Operators, however they will pay CP5 rates for any additional or new services whilst any new entrant Open Access Operator will pay CP4 rates on services below a set threshold and CP5 rates on services above that threshold. </ins><del class="ministerial">Open Access (both passenger and freight) VTAC at CP4 levels, whilst</del> Franchised Operators pay the new, higher CP5 rates<del class="ministerial">.</del> <ins class="ministerial">for both existing and new services.  However, this is the only element of VTAC that is calculated on a different basis.</ins></p><p> </p>
answering member printed Baroness Kramer more like this
question first answered
less than 2014-10-28T15:24:42.437Zmore like thismore than 2014-10-28T15:24:42.437Z
question first ministerially corrected
less than 2015-01-12T16:11:35.18Zmore like thismore than 2015-01-12T16:11:35.18Z
answering member
1557
label Biography information for Baroness Kramer more like this
previous answer version
24717
answering member printed Baroness Kramer more like this
answering member
1557
label Biography information for Baroness Kramer more like this
tabling member
2483
label Biography information for Lord Bradshaw more like this
100080
registered interest false more like this
date less than 2014-10-21more like thismore than 2014-10-21
answering body
Attorney General more like this
answering dept id 88 more like this
answering dept short name Attorney General more like this
answering dept sort name Attorney General more like this
hansard heading Judicial Review more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Attorney General, how many judicial reviews there were involving Government departments according to records held by the (a) Treasury Solicitor and (b) Administrative Court Office in each of the last four years; and how many such reviews were upheld in whole or in part in each such year. more like this
tabling member constituency Hammersmith more like this
tabling member printed
Mr Andy Slaughter more like this
uin 211271 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-28more like thismore than 2014-10-28
answer text <p>The Treasury Solicitor’s Department holds records relating only to those cases in which it has acted. The Treasury Solicitor represents most, but not all, government departments in litigation. For example, Her Majesty’s Revenue and Customs normally conducts its own litigation. According to records held by the Treasury Solicitor, the number of judicial reviews involving government departments in which it has acted in each of the last four years is as follows:</p><p>2010 – 8,566</p><p>2011 – 9,603</p><p>2012 – 10,274</p><p>2013 – 16,449</p><p>Information relating to how many of those reviews were upheld in whole or in part in each year is not held centrally and could not be created without incurring disproportionate cost.</p><p><del class="ministerial">The Administrative Court Office does not collate the information requested centrally and determining the number of reviews and how many such reviews were upheld in whole or in part would incur a disproportionate cost.</del></p><p><ins class="ministerial">The information requested in respect of the Administrative Court Office is published online at <a href="https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267408/additional-court-tables-2012.xls" target="_blank">https://www.gov.uk/government/uploads/system/uploads/attachment_data/file/267408/additional-court-tables-2012.xls</a> . The 2013 data is not currently available.</ins></p>
answering member constituency South Swindon more like this
answering member printed Mr Robert Buckland more like this
question first answered
less than 2014-10-28T15:10:43.167Zmore like thismore than 2014-10-28T15:10:43.167Z
question first ministerially corrected
less than 2015-01-05T17:35:17.82Zmore like thismore than 2015-01-05T17:35:17.82Z
answering member
4106
label Biography information for Sir Robert Buckland more like this
previous answer version
24759
answering member constituency South Swindon more like this
answering member printed Mr Robert Buckland more like this
answering member
4106
label Biography information for Sir Robert Buckland more like this
tabling member
1516
label Biography information for Andy Slaughter more like this
100157
registered interest false more like this
date less than 2014-10-21more like thismore than 2014-10-21
answering body
Department for Energy and Climate Change more like this
answering dept id 63 more like this
answering dept short name Energy and Climate Change more like this
answering dept sort name Energy and Climate Change more like this
hansard heading Energy: Prices more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Energy and Climate Change, what estimate he has made of the likely total allocation from the levy control framework for (a) feed in tariffs, (b) renewables obligations and (c) projects agreed under the final investment decision-enabling process in each year from 2015 to 2021. more like this
tabling member constituency Rutherglen and Hamilton West more like this
tabling member printed
Tom Greatrex more like this
uin 211400 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-24more like thismore than 2014-10-24
answer text <p>The projected allocation from the levy control framework for feed in tariffs, the renewables obligation and projects agreed under the final investment decision-enabling process in financial years from 2015/16 to 2020/21 <del class="ministerial">will be</del> <ins class="ministerial">is expected to be</ins> published in an annex (‘DECC’s Consumer Funded Policies – a report to Parliament’) to the Annual Energy Statement.</p><p>Publication of the Annual Energy Statement is expected in Autumn 2014.</p><p> </p><p> </p><p> </p> more like this
answering member constituency West Suffolk more like this
answering member printed Matthew Hancock more like this
question first answered
less than 2014-10-24T13:35:38.18Zmore like thismore than 2014-10-24T13:35:38.18Z
question first ministerially corrected
less than 2014-10-28T16:37:54.0238756Zmore like thismore than 2014-10-28T16:37:54.0238756Z
answering member
4070
label Biography information for Matt Hancock more like this
previous answer version
24144
answering member constituency West Suffolk more like this
answering member printed Matthew Hancock more like this
answering member
4070
label Biography information for Matt Hancock more like this
tabling member
4047
label Biography information for Tom Greatrex more like this
100186
registered interest false more like this
date less than 2014-10-21more like thismore than 2014-10-21
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Patients: Safety more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, whether missed or inadequate hydrocortisone administration is included in the NHS list of Never Events. more like this
tabling member constituency Oxford East more like this
tabling member printed
Mr Andrew Smith more like this
uin 211233 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-28more like thismore than 2014-10-28
answer text <p>Missed or inadequate hydrocortisone administration is not currently included in the list of ‘never events’.</p><p> </p><p> </p><p> </p><p>We can confirm that the current list of Never Events is under review and there is a consultation underway which opened online on the 6 October 2014 and closes on 31 October 2014.</p><p> </p> more like this
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-28T15:28:25.797Zmore like thismore than 2014-10-28T15:28:25.797Z
question first ministerially corrected
less than 2014-10-28T16:30:53.2329022Zmore like thismore than 2014-10-28T16:30:53.2329022Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
24770
answering member constituency Battersea more like this
answering member printed Jane Ellison more like this
answering member 3918
tabling member
95
label Biography information for Mr Andrew Smith more like this
1002115
registered interest false more like this
date remove maximum value filtermore like thismore than 2018-11-05
answering body
Ministry of Justice more like this
answering dept id 54 more like this
answering dept short name Justice more like this
answering dept sort name Justice more like this
hansard heading Probation: Death more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Justice, pursuant to the Answer of 1 November 2018 to Question 184996 on Probation: Death, if he will provide that information for each year since 2010. more like this
tabling member constituency Leeds East more like this
tabling member printed
Richard Burgon more like this
uin 188194 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2018-11-14more like thismore than 2018-11-14
answer text <p>The information requested is provided in the attached table. As per the answer to PQ 184996, please note that offenders may appear both within the caseload figures of court orders (including community orders and suspended sentence orders), and post-release supervision.</p><p> </p><p>The National Probation Service and Community Rehabilitation Companies work closely with other agencies to support offenders in the community. When an offender being supervised by Probation dies, the Probation provider must examine the circumstances of the death and identify areas to improve practice. While we work extremely closely with each offender before and after release to help them find the support they need, we do not have sole responsibility for caring for these offenders. We are clear, however, that they should receive the same level of care as other members of the public.</p> more like this
answering member constituency Penrith and The Border more like this
answering member printed Rory Stewart more like this
question first answered
less than 2018-11-14T17:01:11.393Zmore like thismore than 2018-11-14T17:01:11.393Z
question first ministerially corrected
less than 2018-11-21T11:59:57.143Zmore like thismore than 2018-11-21T11:59:57.143Z
answering member
4137
label Biography information for Rory Stewart more like this
attachment
1
file name PQ 188194 - table.xlsx more like this
title PQ188194 - Table more like this
previous answer version
84891
answering member constituency Penrith and The Border more like this
answering member printed Rory Stewart more like this
answering member
4137
label Biography information for Rory Stewart more like this
tabling member
4493
label Biography information for Richard Burgon more like this
100630
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department for Transport more like this
answering dept id 27 more like this
answering dept short name Transport more like this
answering dept sort name Transport more like this
hansard heading Railways: North West more like this
house id 2 more like this
legislature
25277
pref label House of Lords more like this
question text To ask Her Majesty’s Government what assessment they have made of the case for improving inter-regional rail links in the North West of England, particularly between East Lancashire and Greater Manchester. more like this
tabling member printed
Baroness Massey of Darwen more like this
uin HL2361 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-30more like thismore than 2014-10-30
answer text <p>The case for improving inter-regional rail links in the North West of England has been assessed in a number of studies including the Northern Hub and Network Rail’s Lancashire and Cumbria and North-West Route Utilisation strategies. The case will be further addressed in respect of Network Rail’s Control Period 6 (2019-20<ins class="ministerial">2</ins><del class="ministerial">1</del>4) and beyond through the Northern Route Study as part of Network Rail’s Long Term Planning Process to inform decisions on the Government’s Rail Investment Strategy for Control Period 6.</p> more like this
answering member printed Baroness Kramer more like this
question first answered
less than 2014-10-30T12:12:57.52Zmore like thismore than 2014-10-30T12:12:57.52Z
question first ministerially corrected
less than 2014-11-05T12:17:05.0180707Zmore like thismore than 2014-11-05T12:17:05.0180707Z
answering member
1557
label Biography information for Baroness Kramer more like this
previous answer version
25208
answering member printed Baroness Kramer more like this
answering member
1557
label Biography information for Baroness Kramer more like this
tabling member
2489
label Biography information for Baroness Massey of Darwen more like this
100721
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Osteoporosis more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the publich purse has been spent on research into osteoporosis in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211732 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100723
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Motor Neurone Disease: Drugs more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on the development of new drugs to prevent or treat symptoms of motore neurone disease in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211734 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this
100728
registered interest false more like this
date less than 2014-10-23more like thismore than 2014-10-23
answering body
Department of Health more like this
answering dept id 17 more like this
answering dept short name Health more like this
answering dept sort name Health more like this
hansard heading Motor Neurone Disease more like this
house id 1 more like this
legislature
25259
pref label House of Commons more like this
question text To ask the Secretary of State for Health, how much from the public purse has been spent on research into motor neurone disease in each of the last five years. more like this
tabling member constituency Leicester West more like this
tabling member printed
Liz Kendall more like this
uin 211730 more like this
answer
answer
is ministerial correction true more like this
date of answer less than 2014-10-29more like thismore than 2014-10-29
answer text <p>The following table shows estimated expenditure on research on asthma, motor neurone disease (MND) and osteoporosis by the Medical Research Council, other Research Councils and Innovate UK, and by the National Institute for Health (NIHR) through its research programmes, research centres and units, and research fellowships.</p><p> </p><p> </p><p> </p><p><em>£ million</em></p><p> </p><table><tbody><tr><td> </td><td><p>2009-10</p></td><td><p>2010-11</p></td><td><p>2011-12</p></td><td><p>2012-13</p></td><td><p>2013-14</p></td></tr><tr><td colspan="6"><p>Asthma</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p><del class="ministerial">22.2 </del><ins class="ministerial">6.6</ins></p></td><td><p><del class="ministerial">17.5 </del><ins class="ministerial">5.3</ins></p></td><td><p><del class="ministerial">17.2</del><ins class="ministerial"> 4.5</ins></p></td><td><p><del class="ministerial">19.4</del><ins class="ministerial"> 3.6</ins></p></td><td><p><del class="ministerial">18.8</del><ins class="ministerial"> 5.4</ins></p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.3</p></td><td><p>1.5</p></td><td><p>0.8</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>2.6</p></td><td><p>3.4</p></td><td><p>2.4</p></td><td><p>3.4</p></td><td><p>3.8</p></td></tr><tr><td><p>Total</p></td><td><p><del class="ministerial">24.8</del><ins class="ministerial"> 9.2</ins></p></td><td><p><del class="ministerial">21.0</del><ins class="ministerial"> 8.8</ins></p></td><td><p><del class="ministerial">19.9</del><ins class="ministerial"> 7.2</ins></p></td><td><p><del class="ministerial">24.3 </del><ins class="ministerial">8.5</ins></p></td><td><p><del class="ministerial">23.4</del> <ins class="ministerial">10.0</ins></p></td></tr><tr><td colspan="6"><p>Motor Neurone Research</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>7.0</p></td><td><p>7.5</p></td><td><p>4.2</p></td><td><p>4.1</p></td><td><p>3.6</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.2</p></td><td><p>0.2</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.1</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>0.7</p></td><td><p>0.5</p></td></tr><tr><td><p>Total</p></td><td><p>7.3</p></td><td><p>7.8</p></td><td><p>5.0</p></td><td><p>5.5</p></td><td><p>5.1</p></td></tr><tr><td colspan="6"><p>Osteoporosis</p></td></tr><tr><td><p>Medical Research Council</p></td><td><p>6.2</p></td><td><p>5.4</p></td><td><p>5.1</p></td><td><p>4.6</p></td><td><p>5.9</p></td></tr><tr><td><p>Other Research Councils and Innovate UK</p></td><td><p>0.0</p></td><td><p>0.0</p></td><td><p>0.1</p></td><td><p>0.4</p></td><td><p>1.0</p></td></tr><tr><td><p>National Institute for Health Research</p></td><td><p>0.3</p></td><td><p>0.7</p></td><td><p>0.8</p></td><td><p>1.3</p></td><td><p>1.8</p></td></tr><tr><td><p>Total</p></td><td><p>6.5</p></td><td><p>6.1</p></td><td><p>6.0</p></td><td><p>6.3</p></td><td><p>8.7</p></td></tr></tbody></table><p> </p><p> </p><p> </p><p>The figures shown for asthma exclude research into air pollution and potential effects on health outcomes including asthma.</p><p> </p><p> </p><p> </p><p>Total spend by the NIHR on asthma, MND and osteoporosis is higher than the figures shown because expenditure by the NIHR Clinical Research Network (CRN) on these diseases cannot be disaggregated from total CRN expenditure. NIHR expenditure relating to development of new drugs for asthma, MND and osteroporosis occurs primarily through NIHR research infrastructure including the CRN and cannot be disaggregated from total expenditure.</p><p> </p><p> </p><p> </p><p>Information on MRC expenditure into the development of new drugs for asthma, MND or osteoporosis is not available.</p><p> </p>
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
question first answered
less than 2014-10-29T17:12:28.3318918Zmore like thismore than 2014-10-29T17:12:28.3318918Z
question first ministerially corrected
less than 2014-11-13T10:22:56.0372213Zmore like thismore than 2014-11-13T10:22:56.0372213Z
answering member
4020
label Biography information for George Freeman more like this
previous answer version
25123
answering member constituency Mid Norfolk more like this
answering member printed George Freeman more like this
answering member
4020
label Biography information for George Freeman more like this
tabling member
4026
label Biography information for Liz Kendall more like this